Results 21 to 30 of about 1,679,263 (303)

Associations between cardiac structure and function and depressive disorder: A centenarian study in China

open access: yesHeliyon, 2023
Background: Depressive disorder is a common comorbidity in patients with cardiovascular diseases and is associated with increased hospitalization and death rates.
Zhigao Sun   +7 more
doaj   +1 more source

Genome-wide association study of major depressive disorder: new results, meta-analysis, and lessons learned [PDF]

open access: yes, 2010
Major depressive disorder (MDD) is a common complex disorder with a partly genetic etiology. We conducted a genome-wide association study of the MDD2000+ sample (2431 cases, 3673 screened controls and >1 M imputed single-nucleotide polymorphisms (SNPs)).
D I Boomsma   +145 more
core   +2 more sources

Putative Transcriptomic Biomarkers in the Inflammatory Cytokine Pathway Differentiate Major Depressive Disorder Patients from Control Subjects and Bipolar Disorder Patients [PDF]

open access: yes, 2014
Mood disorders consist of two etiologically related, but distinctly treated illnesses, major depressive disorder (MDD) and bipolar disorder (BPD). These disorders share similarities in their clinical presentation, and thus show high rates of misdiagnosis.
Farmer, A.   +76 more
core   +1 more source

Sleep deprivation in bright and dim light: antidepressant effects on major depressive disorder [PDF]

open access: yes, 1990
Twenty-three patients with a major depressive disorder were deprived of a night’s sleep twice weekly, one week staying up in the dimly lit living room of the ward (< 60 lux), and one week in a brightly lit room (> 2000 lux).
Bouhuys, A.L.   +7 more
core   +1 more source

Serum level of soluble interleukin 6 receptor is a useful biomarker for identification of treatment‐resistant major depressive disorder

open access: yesNeuropsychopharmacology Reports, 2020
Aim A substantial proportion of major depressive disorder patients are treatment‐resistant to antidepressant therapy, who require augmentation drugs, or other treatments including electroconvulsive therapy or transcranial magnetic stimulation ...
Katsuhiko Yamasaki   +2 more
doaj   +1 more source

Features of minor depressive disorder subtypes in conditions of COVID-19 pandemic

open access: yesIndian Journal of Psychiatry, 2020
Background: The continuous research on minor depressive disorder is one of the pressing issues in the context of the COVID-19 pandemic. We studied the features of minor depressive disorder subtypes in conditions of the COVID-19 pandemic.
Shokhrukh Sultanov   +4 more
doaj   +1 more source

Depressive disorder at the household level: prevalence and correlates of depressive symptoms among household members

open access: yesGlobal Health Action, 2023
Background Globally, an estimated five percent of adults have major depressive disorder. However, little is known about the relationship between these individuals’ depressive symptoms and their household members’ mental health and well-being.
Kondwani Mpinga   +13 more
doaj   +1 more source

Evaluation of olfactory bulb volume and olfactory sulcus depth in patients with panic disorder and depressive disorder: An MRI study

open access: yesIndian Journal of Psychiatry, 2022
Background: Although some studies have shown decreases in the olfactory bulb (OB) volume and olfactory function in depressive disorder, there are no studies investigating OB volume in patients with panic disorder.
Gül Ferda Cengiz   +2 more
doaj   +1 more source

Distinguish bipolar and major depressive disorder in adolescents based on multimodal neuroimaging: Results from the Adolescent Brain Cognitive Development study

open access: yesDigital Health, 2022
Background Major depressive disorder and bipolar disorder in adolescents are prevalent and are associated with cognitive impairment, executive dysfunction, and increased mortality. Early intervention in the initial stages of major depressive disorder and
Yujun Liu   +9 more
doaj   +1 more source

Joint analysis of psychiatric disorders increases accuracy of risk prediction for schizophrenia, bipolar disorder, and major depressive disorder [PDF]

open access: yes, 2015
Genetic risk prediction has several potential applications in medical research and clinical practice and could be used, for example, to stratify a heterogeneous population of patients by their predicted genetic risk.
Caesar, Sian   +858 more
core   +3 more sources

Home - About - Disclaimer - Privacy